CellSeed Inc. Stock

Equities

7776

JP3423530009

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-04-23 am EDT 5-day change 1st Jan Change
208 JPY -1.42% Intraday chart for CellSeed Inc. -1.89% -23.25%
Sales 2020 199M 1.29M Sales 2021 161M 1.04M Capitalization 3.27B 21.11M
Net income 2020 -783M -5.06M Net income 2021 -914M -5.9M EV / Sales 2020 12.4 x
Net cash position 2020 1.3B 8.4M Net cash position 2021 771M 4.98M EV / Sales 2021 15.5 x
P/E ratio 2020
-4.47 x
P/E ratio 2021
-3.46 x
Employees 44
Yield 2020 *
-
Yield 2021
-
Free-Float 94.75%
More Fundamentals * Assessed data
Dynamic Chart
CellSeed Inc. announced that it has received ¥2.001 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it expects to receive ¥2.001 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it has received ¥1.144 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it expects to receive ¥1.144 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it has received ¥3.78 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it expects to receive ¥3.78 million in funding from Barclays Bank PLC, Investment Arm CI
CellSeed Inc. announced that it has received ¥2.884 million in funding CI
An unknown buyer acquired 0.34% stake in CellSeed Inc. from Emmaus Life Sciences, Inc. for $0.22 million. CI
CellSeed Inc. announced that it expects to receive ¥2.884 million in funding CI
CellSeed Inc. announced that it has received ¥6.6 million in funding from Evolution Capital Management, LLC CI
CellSeed Inc. announced that it expects to receive ¥6.6 million in funding from Evolution Capital Management, LLC CI
CellSeed Inc.(JASDAQ:7776) dropped from S&P Global BMI Index CI
CellSeed Inc. announced that it has received ¥6.4 million in funding from Milestone Capital Management Co., Ltd. CI
CellSeed Inc. announced that it expects to receive ¥6.4 million in funding from Milestone Capital Management Co., Ltd.. CI
CellSeed Inc. Announces Management Changes CI
More news
1 day-1.42%
1 week-1.89%
Current month-5.45%
1 month-5.45%
3 months-19.69%
6 months-32.03%
Current year-23.25%
More quotes
1 week
201.00
Extreme 201
213.00
1 month
201.00
Extreme 201
233.00
Current year
201.00
Extreme 201
284.00
1 year
201.00
Extreme 201
516.00
3 years
122.00
Extreme 122
984.00
5 years
122.00
Extreme 122
984.00
10 years
122.00
Extreme 122
2 020.00
More quotes
Managers TitleAgeSince
President 70 14-02-28
Members of the board TitleAgeSince
President 70 14-02-28
Director/Board Member 60 11-02-28
Director/Board Member 72 17-02-28
More insiders
Date Price Change Volume
24-04-23 208 -1.42% 164 400
24-04-22 211 +3.43% 219,700
24-04-19 204 -3.32% 366,300
24-04-18 211 +2.43% 179,600
24-04-17 206 -2.83% 203,500

Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT

More quotes
CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
More about the company